| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 88786 |
氨基聚乙二醇功能化的金纳米粒,AuNP-PEG-NH |
198 |
wyh |
2024-12-03 |
| 88787 |
Gd-DOTA修饰星形两亲性葡聚糖胶束 |
127 |
wyh |
2024-12-03 |
| 88788 |
IRFE-PEG-DOTA(IPD), 近红外二区(NIR II)有机染料 |
221 |
wyh |
2024-12-03 |
| 88789 |
[18F]FN-PEG4-Tz-TCO-GK-PEG4-5F7 ([18F]FN-GK-5F7) |
158 |
WYQ |
2024-12-03 |
| 88790 |
64Cu]Cu-NOTA-PEG7-H-Tz |
168 |
WYQ |
2024-12-03 |
| 88791 |
DOTA-PEG-DSPE ,DOTA-聚乙二醇-磷脂 |
136 |
wyh |
2024-12-03 |
| 88792 |
3,6-二氨基-1,2,4,5-四嗪(DATZ) |
129 |
WYQ |
2024-12-03 |
| 88793 |
DOTA-PEG(4)-BBN ;DOTA-四聚乙二醇-铃蟾肽 |
138 |
wyh |
2024-12-03 |
| 88794 |
3,6-二氨基-1,2,4,5-四嗪-1,4-二氧化物 |
177 |
WYQ |
2024-12-03 |
| 88795 |
1,6-二氢-1,2,4,5-四嗪化合物(1,6-Dihydro-1,2,4,5-Tetrazines) |
223 |
WYQ |
2024-12-03 |
| 88796 |
TCO-CC49 ,TCO功能化CC49抗体 |
187 |
wyh |
2024-12-03 |
| 88797 |
[111In]In-DOTA-PEG11-BisPy-Tz |
171 |
WYQ |
2024-12-03 |
| 88798 |
3,6-二烷基-1,2,4,5-四嗪(或-s-四嗪);3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) |
138 |
WYQ |
2024-12-03 |
| 88799 |
3,6-二烷基-1,2,4,5-四嗪(或-s-四嗪);3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) |
137 |
WYQ |
2024-12-03 |
| 88800 |
3,6-双(2-吡啶基)-1,2,4,5-四嗪(bptz);3,6-bis(2-pyridyl)-1,2,4,5-tetrazine |
166 |
WYQ |
2024-12-03 |
| 88801 |
(DOTA)5-decalysine , (DOTA)5-十氢赖氨酸 |
119 |
wyh |
2024-12-03 |
| 88802 |
3,6-dihydrazino-1,2,4,5-tetrazine(DHT) |
150 |
WYQ |
2024-12-03 |
| 88803 |
5-TAMRA-Tz;S-四嗪近红外花菁染料;5-TAMRA-tetrazine |
171 |
WYQ |
2024-12-03 |
| 88804 |
[64Cu]Cu-SarAr-Tz;(64)Cu标记四嗪放射性配体 |
267 |
WYQ |
2024-12-03 |
| 88805 |
DOTA-monoamide,DOTA-单酰胺复合物 |
132 |
wyh |
2024-12-03 |
| 88806 |
DOTA-PEG-RGD, DOTA-聚乙二醇-多肽 |
202 |
wyh |
2024-12-03 |
| 88807 |
DOTA-PEGn-Cys-VS ,单分散PEG偶联螯合剂DO |
155 |
wyh |
2024-12-03 |
| 88808 |
甲氧基DOTA ,MeO-DOTA |
331 |
wyh |
2024-12-03 |
| 88809 |
DOTA-BASS , DOTA偶联sst拮抗剂 |
314 |
wyh |
2024-12-03 |
| 88810 |
DOTA-phenylalanine,DOTA-苯丙氨酸 |
151 |
wyh |
2024-12-03 |
| 88811 |
DOTA−Lysine−Biotin, DOTA -赖氨酸-生物素 |
147 |
wyh |
2024-12-03 |
| 88812 |
DOTA-GA,螯合剂DOTA肽缀合物 |
161 |
wyh |
2024-12-03 |
| 88813 |
DOTA共轭二膦酸盐,DOTA-HBP |
159 |
wyh |
2024-12-03 |
| 88814 |
DOTA-神经介素n ,DOTA-Neuromedin N |
139 |
wyh |
2024-12-03 |
| 88815 |
tris-烯丙基-DOTA , tris-allyl-DOTA |
139 |
wyh |
2024-12-03 |
| 88816 |
6-(苄氧羰基)氨基-3-(甲硫基)-1,2,4-四嗪;6-(benzyloxycarbonyl)amino-3-(methylthio)-1,2,4,5-tetrazine |
148 |
WYQ |
2024-12-03 |
| 88817 |
6-(乙酰氨基)-3-(甲硫基)-1,2,4-四嗪;6-(acetylamino)-3-(methylthio)-1,2,4,5-tetrazine |
167 |
WYQ |
2024-12-03 |
| 88818 |
cFLFLFK-PEG-DOTA ;细胞特异性肽-聚乙二醇-DOTA |
124 |
wyh |
2024-12-03 |
| 88819 |
6-[(叔丁氧基羰基)氨基]-3-(甲硫基)-1,2,4-四嗪;6-[(tert-butyloxycarbonyl)amino]-3-(methylthio)-1,2,4,5-tetrazine |
149 |
WYQ |
2024-12-03 |
| 88820 |
MMA-DOTA-Cys 61 ,DOTA-马来酰亚胺-半胱氨酸 |
170 |
wyh |
2024-12-03 |
| 88821 |
DOTA-BR96 ,DOTA标记BR96单克隆抗体 |
160 |
wyh |
2024-12-03 |
| 88822 |
DOTA-ggNle-cycmsh(hex),内酰胺桥环化肽偶联DOTA |
150 |
wyh |
2024-12-03 |
| 88823 |
DOTA-sCCK8[Phe2(p-CH2SO3H) ,大环DOTA偶联多肽 |
156 |
wyh |
2024-12-03 |
| 88824 |
3,6-双(1H-1,2,3,4-四唑-5-基氨基)-1,2,4,5-四嗪(BTATz);3,6-bis(1H-1,2,3,4-tetrazol-5-yl-amino)- 1,2,4,5-tetrazine |
151 |
WYQ |
2024-12-03 |
| 88825 |
3,3'-偶氮二(6-氨基-1,2,4,5-四嗪)(DAAT);3,3'-azobis(6-amino-1,2,4,5-tetrazine) |
316 |
WYQ |
2024-12-03 |
| 88826 |
c(DOTA-RGDf),大环螯合剂DOTA环化RGD肽序列 |
160 |
wyh |
2024-12-03 |
| 88827 |
3,6-双(吡啶-3-基)-1,2,4,5-四嗪(3,3'-吡喃);3,6-bis(pyridin-3-yl)-1,2,4,5-tetrazine (3,3'-pytz) |
159 |
WYQ |
2024-12-03 |
| 88828 |
3,6-双(2-甲氧基苯基)-1,2-二氢-1,2,4,5-四嗪(2-MDHT);3,6-bis(2-methoxyphenyl)-1,2-dihydro-1,2,4,5-tetrazine |
172 |
WYQ |
2024-12-03 |
| 88829 |
3,6-二甲基-1,2,4,5-四嗪;3,6-Dimethyl-1,2,4,5-tetrazine |
169 |
WYQ |
2024-12-03 |
| 88830 |
3,3'-偶氮(6-氨基-1,2,4,5-四嗪);3,3'-Azobis(6-amino-1,2,4,5-tetrazine)(DAAT) |
205 |
WYQ |
2024-12-03 |